| Pharmaceutical Information |
| Drug Name |
Phenylbutazone |
| Drug ID |
BADD_D02631 |
| Description |
A drug that has anti-inflammatory, antipyretic, and analgesic activities. It is especially effective in the treatment of ankylosing spondylitis. It also is useful in rheumatoid arthritis and Reiter's syndrome (investigational indication). Although phenylbutazone is effective in gouty arthritis, risk/benefit considerations indicate that this drug should not be employed for this disease. (From AMA Drug Evaluations Annual, 1994, p1822) |
| Indications and Usage |
For the treatment of backache and ankylosing spondylitis |
| Marketing Status |
approved; vet_approved |
| ATC Code |
M01AA01; M02AA01 |
| DrugBank ID |
DB00812
|
| KEGG ID |
D00510
|
| MeSH ID |
D010653
|
| PubChem ID |
4781
|
| TTD Drug ID |
D07VHR
|
| NDC Product Code |
51552-1562; 59348-0010; 49452-5285; 60592-909; 51927-1011; 66064-1050 |
| UNII |
GN5P7K3T8S
|
| Synonyms |
Phenylbutazone | Diphenylbutazone | Butazolidin | Butadione | Butadion | Butacote | Butapyrazole | Butapirazol | Fenilbutazon |
|
| Chemical Information |
| Molecular Formula |
C19H20N2O2 |
| CAS Registry Number |
50-33-9 |
| SMILES |
CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
